Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1918 in Patients With Hypertriglyceridemia
NCT07349615Phase 3Active, not recruiting
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-1918 in hypertriglyceridemia, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Mar 2026; status: active, not recruiting.
02
Drugs
SHR-1918
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT07349615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349615.